Forecasting the rate of hemolytic disease of the fetus and newborn in the United States based on recent trends in prehospital transfusion
Transfusion · 05.11.2026
DOI: 10.1111/trf.70478 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion, online erschienen am 05.11.2026. Verfasst von Adnan S Syed und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
As prehospital transfusion becomes more common in the United States (US), cases of hemolytic disease of the fetus and newborn (HDFN) might increase. This study forecasted the number of HDFN cases in 2029 resulting from RhD‐positive prehospital transfusions. Study Design and Methods A regression was performed on the number of females of childbearing potential (FCP) who received RhD‐positive prehospital transfusions between 2020 and 2024 in the US to forecast the total number of FCPs who would receive transfusions in 2029. Then, a model using current nativity and population demographics was used to calculate the regional rate of HDFN in 2029 (Model 1). In addition, the frequency of transfusing FCPs in the four US census regions in 2029 was varied based upon the regional uptake of prehospital low titer group O whole blood transfusion between 2024 and 2025 (Model 2) and the uptake of prehospital transfusion by ground ambulances between 2019 and 2026 (Model 3). Each model was instantiated 500 times.
Results
It was forecasted that 779 FCPs would receive prehospital transfusions in 2029 throughout the US. In Model 1, the number of years required for one case of HDFN to occur was calculated to range from 0.5 (South)–20.0 (Northeast). When the regional frequency of providing prehospital transfusions was varied, the number of years required for one case of HDFN to occur ranged from 0.6 (South)–13.5 (Northeast) (Model 2), and between 0.7 (South)–4.6 (Northeast) (Model 3).
Discussion
As prehospital transfusions increase, the risk of HDFN is predicted to also increase.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- Division of Hematopathology, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Pathology, University of Utah, Salt Lake City, Utah, USA.
- US Army Institute of Surgical Research, JBSA Fort Sam Houston, Texas, USA.
- Department of Emergency Medicine, Brooke Army Medical Center, JBSA Fort Sam Houston, San Antonio, Texas, USA.
- Center for Combat and Battlefield (COMBAT) Research, University of Colorado School of Medicine, Aurora, Colorado, USA.
ORCID-Profile: Adnan S Syed, Jansen R Seheult, Casey Vieni, Steven G Schauer, Randall Schaefer, Matthew J Levy, Mark H Yazer
Zitieren
APA
Syed, A. S., Seheult, J. R., Vieni, C., Schauer, S. G., Schaefer, R., Levy, M. J., & Yazer, M. H. (2026). Forecasting the rate of hemolytic disease of the fetus and newborn in the United States based on recent trends in prehospital transfusion. Transfusion. https://doi.org/10.1111/trf.70478
Vancouver
Syed AS, Seheult JR, Vieni C, Schauer SG, Schaefer R, Levy MJ, et al. Forecasting the rate of hemolytic disease of the fetus and newborn in the United States based on recent trends in prehospital transfusion. Transfusion. 2026. doi:10.1111/trf.70478
BibTeX
@article{Syed2026,
author = {Syed, Adnan S and Seheult, Jansen R and Vieni, Casey and Schauer, Steven G and Schaefer, Randall and Levy, Matthew J and Yazer, Mark H},
title = {Forecasting the rate of hemolytic disease of the fetus and newborn in the United States based on recent trends in prehospital transfusion},
journal = {Transfusion},
year = {2026},
doi = {10.1111/trf.70478}
}
EUVIMED